Literature DB >> 3031609

Identification of an Epstein-Barr virus-specific desoxyribonuclease gene using complementary DNA.

C X Zhang, G Decaussin, M de Turenne Tessier, J Daillie, T Ooka.   

Abstract

We have recently obtained 18 distinct cDNA clones representing different genes expressed in the early phase of EBV infection. One of them, c37, which is situated at the position 12907-122451 in the B95-8 viral genome, is shown here to code for a viral desoxyribonuclease [DNase]. Cell free translation of c37-selected messenger RNA yielded a protein of about 52 KDa which was immunoprecipitated by a high EA titer serum from nasopharyngeal carcinoma patient. This protein showed a DNase activity which was resistant to high salt concentrations (150 to 300 mM KCl) and was specifically neutralized by EA positive serum. These properties are typical of the EBV-specific DNase activity that we recently described in chemically induced EBV-transformed lymphoid cells. The same results were obtained on cell-free translation of the native RNA synthesized in vitro from pGEM-37 plasmid containing the entire c37 cDNA sequence (1.53 Kb). These data indicate that the BGLF5 open reading frame contained in c37 encodes for the EBV-specific DNase.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3031609      PMCID: PMC340679          DOI: 10.1093/nar/15.6.2707

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  23 in total

1.  Deoxyribonuclease activity found in Epstein--Barr virus producing lymphoblastoid cells.

Authors:  W Clough
Journal:  Biochemistry       Date:  1979-10-16       Impact factor: 3.162

2.  Persisting oncogenic herpesvirus induced by the tumour promotor TPA.

Authors:  H zur Hausen; F J O'Neill; U K Freese; E Hecker
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

3.  DNA sequence of the region in the genome of herpes simplex virus type 1 containing the exonuclease gene and neighbouring genes.

Authors:  D J McGeoch; A Dolan; M C Frame
Journal:  Nucleic Acids Res       Date:  1986-04-25       Impact factor: 16.971

4.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

5.  Promoter sequences of eukaryotic protein-coding genes.

Authors:  J Corden; B Wasylyk; A Buchwalder; P Sassone-Corsi; C Kedinger; P Chambon
Journal:  Science       Date:  1980-09-19       Impact factor: 47.728

6.  Effect of n-butyrate on cellular and viral DNA synthesis in cells latently infected with Epstein-Barr virus.

Authors:  A K Saemundsen; B Kallin; G Klein
Journal:  Virology       Date:  1980-12       Impact factor: 3.616

7.  Studies on the activity of DNase associated with the replication of the Epstein-Barr virus.

Authors:  Y C Cheng; J Y Chen; P J Hoffmann; R Glaser
Journal:  Virology       Date:  1980-01-30       Impact factor: 3.616

8.  Effects of arabinofuranosylthymine on Epstein-Barr virus replication.

Authors:  T Ooka; A Calender
Journal:  Virology       Date:  1980-07-15       Impact factor: 3.616

9.  Alkaline deoxyribonuclease induced by herpes simplex virus type 1: composition and properties of the purified enzyme.

Authors:  M Strobel-Fidler; B Francke
Journal:  Virology       Date:  1980-06       Impact factor: 3.616

10.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

View more
  10 in total

Review 1.  Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases.

Authors:  T Ooka; M de Turenne-Tessier; M C Stolzenberg
Journal:  Springer Semin Immunopathol       Date:  1991

2.  The Epstein-Barr virus alkaline exonuclease BGLF5 serves pleiotropic functions in virus replication.

Authors:  R Feederle; H Bannert; H Lips; N Müller-Lantzsch; H-J Delecluse
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

3.  The Epstein-Barr virus protein kinase BGLF4 and the exonuclease BGLF5 have opposite effects on the regulation of viral protein production.

Authors:  Regina Feederle; Anja M Mehl-Lautscham; Helmut Bannert; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

4.  Relative rates of RNA synthesis across the genome of Epstein-Barr virus are highest near oriP and oriLyt.

Authors:  S Metzenberg
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

5.  The analysis of EBV proteins which are antigenic in vivo.

Authors:  D Walls; M Perricaudet; F Gannon
Journal:  Nucleic Acids Res       Date:  1988-04-11       Impact factor: 16.971

6.  Altered expression of two Epstein-Barr virus early genes localized in BamHI-A in nonproducer Raji cells.

Authors:  C X Zhang; G Decaussin; J Daillie; T Ooka
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

7.  Purification and properties of Epstein-Barr virus DNase expressed in Escherichia coli.

Authors:  M C Stolzenberg; T Ooka
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

8.  A transforming function of the BARF1 gene encoded by Epstein-Barr virus.

Authors:  M X Wei; T Ooka
Journal:  EMBO J       Date:  1989-10       Impact factor: 11.598

9.  Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells.

Authors:  Chung-Chun Wu; Ming-Tsan Liu; Yu-Ting Chang; Chih-Yeu Fang; Sheng-Ping Chou; Hsin-Wei Liao; Kuan-Lin Kuo; Shih-Lung Hsu; Yi-Ren Chen; Pei-Wen Wang; Yu-Lian Chen; Hsin-Ying Chuang; Chia-Huei Lee; Ming Chen; Wun-Shaing Wayne Chang; Jen-Yang Chen
Journal:  Nucleic Acids Res       Date:  2009-12-23       Impact factor: 16.971

10.  A human urine-derived interleukin 1 inhibitor. Homology with deoxyribonuclease I.

Authors:  D L Rosenstreich; J H Tu; P R Kinkade; I Maurer-Fogy; J Kahn; R W Barton; P R Farina
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.